Biopersistence of refractory ceramic fiber in human lung tissue and a 20-year follow-up of radiographic pleural changes in workers

Journal of Occupational and Environmental Medicine

Volumn 54, Issue 7, 2012, Pages 781-788

  Lockey, James E ^a   Roggli, Victor L ^a,b   Hilbert, Timothy J ^a   Rice, Carol H ^a   Levin, Linda S ^a   Borton, Eric K ^a   Biddinger, Paul W ^c,d   Lemasters, Grace K ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY   (United States)

^d MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM SILICATE; CALCIUM PHOSPHATE CERAMIC; IRON OXIDE; SILICON DIOXIDE;

ADULT; ARTICLE; CERAMIC INDUSTRY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL SAFETY; SCANNING ELECTRON MICROSCOPY; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; CERAMICS; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; MINERAL FIBERS; OCCUPATIONAL EXPOSURE; PLEURA;

EID: 84861747826     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e31825296fd     Document Type: Article

References (36)

1. Utell MJ, Maxim LD. Refractory ceramic fiber (RCF) toxicity and epidemiology: A review. Inhalat Toxicol. 2010;22:500-521.
2. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Man-Made Vitreous Fibers (Volume 81). Lyon, France: World Health Organization; 2002;66:339.
3. Mast RW, Maxim LD, Utell MJ, Walker AM. Refractory ceramic fiber: toxicology, epidemiology, and risk analysis-A review. Inhalat Toxicol. 2000;12:359-399.
4. US Navy. Review of the U.S. Navy Exposure Standard for Manufactured Vitreous Fibers. Washington, DC: National Academy Press; 2000:28-29.
5. Roggli VL. Human disease consequences of fiber exposure: A reviewof human lung pathology and fiber burden data. Environ Health Perspect. 1990;88:295-303. (Pubitemid 20352986)
6. Hesterberg TW, Chase G, Axten C, et al. Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation. Toxicol Appl Pharmacol. 1998;151:262-275. (Pubitemid 128421790)
7. Oberdorster G. Determinants of the pathogenicity of man-made vitreous fibers (MMVF). Int Arch Occup Environ Health. 2000;73:S60-S68. (Pubitemid 30487398)
8. Miller BG, Jones AD, Searl A, et al. Influence of characteristics of inhaled fibers on development of tumors in the rat lung. Annals Occup Hyg. 1999;43:167-179. (Pubitemid 29225214)
9. Lockey JE, LeMasters GK, Levin L, et al. A longitudinal study of chest radiographic changes of workers in the refractory ceramic fiber industry. Chest. 2002;121:2044-2051. (Pubitemid 34634433)
10. Lockey J, LeMasters G, Rice C, et al. Refractory ceramic fiber exposure and pleural plaques. Am J Respir Crit Care Med. 1996;154:1405-1410. (Pubitemid 26391189)
11. Cowie HA,Wild P, Beck J, et al. An epidemiological study of the respiratory health of workers in the European refractory ceramic fibre industry. Occup Environ Med. 2001;58:800-810. (Pubitemid 33078980)
12. Clarke CC, Mowat FS, Kelsh MA, Roberts MA. Pleural Plaques: A review of diagnostic issues and possible nonasbestos factors. Arch Environ Occup Health. 2006;61:183-192. (Pubitemid 47311821)
13. Manning CB, Vallyathan V, Mossman BT. Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol. 2002;2:191-200. (Pubitemid 34075410)
14. Mutsaers SE, Prele CM, Brody AR, Idell S. Pathogenesis of pleural fibrosis. Respirology. 2004;9:428-440. (Pubitemid 40179747)
15. LeMasters GK, Lockey JE, Yiin JH, Hilbert TJ, Levin LS, Rice CH. Mortality of workers occupationally exposed to refractory ceramic fibers. J Occup Environ Med. 2003;45:440-450. (Pubitemid 36437894)
16. McKay RT, LeMasters GK, Hilbert TJ, et al. A long-term study of pulmonary function among US refractory ceramic fiber workers. Occup Environ Med. 2011;68:89-95.
17. LeMasters G, Lockey J, Rice C, et al. Radiographic changes among workers manufacturing refractory ceramic fibre and products. Ann Occup Hyg. 1994;38:745-751.
18. Lockey JE, Levin LS, LeMasters GK, et al. Longitudinal estimates of pulmonary function in refractory ceramic fiber manufacturing workers. Am J Respir Crit Care Med. 1998;157:1226-1233.
19. Roggli VL, Sharma A. Analysis of tissue mineral fiber content. In: Roggli VL, Oury TD, Sporn TA, eds. Pathology of Asbestos-Associated Diseases. 2nd ed. New York, NY: Springer; 2004:309-354.
20. Lawson CC, LeMasters MK, LeMasters GK, Reutman SS, Rice CH, Lockey JE. Reliability and validity of chest radiograph surveillance programs. Chest. 2001;120:64-68. (Pubitemid 32744858)
21. Rice CH, Lockey JE, LeMasters GK, Levin LL, Staley P, Hansen KR. Estimation of historical and current employee exposure to refractory ceramic fibers during manufacturing and related operations. Appl Occup Environ Hyg. 1997;12:54-61. (Pubitemid 27033357)
22. Rice CH, Levin LS, Borton EK, Lockey JE, Hilbert TJ, LeMasters GK. Exposures to refractory ceramic fibers in manufacturing and related operations: A 10-year update. J Occup Environ Hyg. 2005;2:462-473. (Pubitemid 41243576)
23. Rice C, Lockey J, LeMasters G, Dimos J, Gartside P. Assessment of current fibre and silica exposure in the U.S. refractory ceramic fibre manufacturing industry. Ann Occup Hyp. 1994;38:739-744.
24. Maxim LD, Mast RW, Utell MJ, et al. Hazard assessment and risk analysis of two new synthetic vitreous fibers. Regul Toxicol Pharmacol. 1999;30: 54-74. (Pubitemid 29439928)
25. Dick JA, Morgan WK, Muir DF, Reger RB, Sargent N. The significance of irregular opacities on the chest roentgenogram. Chest. 1992;102: 251-260.
26. Craighead JE, Abraham JL, Churg A, et al. The pathology of asbestosassociated diseases of the lungs and pleural cavities: diagnostic criteria and proposed grading schema (Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health). Arch Pathol Lab Med. 1982;106: 544-596.
27. Hilbert TJ. Factors associated with reader disagreement in a 20-year radiology study [master's thesis]. Cincinnati, OH: University of Cincinnati; 2009.
28. Hesterberg TW, Hart GA, Chevalier WC, et al. The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats. Toxicol Appl Pharmacol. 1998;153:68-82. (Pubitemid 28563891)
29. Gross P, Tuma J, deTreville RTP. Lungs of workers exposed to fiber glass. Arch Environ Health. 1971;23:67-76.
30. Maxim LD, Hadley JG, Potter RM, Niebo R. The role of fiber durability/biopersistence of silica-based synthetic vitreous fibers and their influence on toxicology. Regul Toxicol Pharmacol. 2006;46:42-62. (Pubitemid 44293041)
31. Lentz TJ, Rice CH, Lockey JE, Succop PA, LeMasters GK. Potential significance of airborne fiber dimensions measured in the U.S. refractory ceramic manufacturing industry. Am J Industr Med. 1999;36:286-298. (Pubitemid 29328192)
32. Churg A, Wright JL, Hobson J, Stevens B. Effects of cigarette smoke on the clearance of short asbestos fibres from the lung and a comparison with the clearance of long asbestos fibres. Int J Exp Pathol. 1992;73:287-297.
33. Churg A, Stevens B. Enhanced retention of asbestos fibers in the airways of human smokers. Am J Respir Crit Care Med. 1995;151:1409-1413.
34. Boutin C, Dumortier P, Rey F, Viallat JR, De Vuyst P. Black spots concentrate oncogenic asbestos fibers in the parietal pleura. Am J Respir Crit Care Med. 1996;153:444-449.
35. Miserocchi G, Sancini G, Mantegazza F, Chiappino G. Translocation pathways for inhaled asbestos fibers. Environ Health. 2008;7:4.
36. Gelzleichter TR, Bermudez E, Mangum JB, Wong BA, Everitt JI, Moss OR. Pulmonary and pleural responses in Fischer 344 rats following shortterm inhalation of a synthetic vitreous fiber. Fund Appl Toxicol. 1996;30: 31-38.